| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $504.1M | +17.1% |
| Cost of Revenue | $131.1M | +6.1% |
| Gross Profit | $373.0M | +21.5% |
| R&D Expense | $137.8M | +21.2% |
| SG&A Expense | $98.7M | +13.2% |
| Operating Income | -$27.4M | +15.0% |
| Pre-tax Income | -$16.1M | +46.0% |
| Income Tax | $2.1M | -1.7% |
| Net Income | -$18.2M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $313.1M | +50.3% |
| Accounts Receivable | $89.7M | -5.7% |
| Current Assets | $455.9M | +33.0% |
| Total Assets | $894.2M | +22.0% |
| Current Liabilities | $349.9M | +16.4% |
| Total Liabilities | $374.4M | +13.5% |
| Stockholders' Equity | $519.8M | +28.9% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $123.5M | +83.7% |
| Capital Expenditures | $1.7M | -31.9% |
| Investing Cash Flow | -$62.9M | -217.1% |
| Financing Cash Flow | $41.2M | +35.8% |
| Free Cash Flow | $121.9M | +88.1% |
| +43.1% |
| EPS (Basic) | -$0.23 | +48.9% |
| EPS (Diluted) | -$0.23 | +48.9% |